David
Feifel, M.D., Ph.D.
Professor, Department of Psychiatry
University of California, San Diego
200 W. Arbor Drive, San Diego, CA 92103-8218
Phone: (619)543-2827
FAX: (619) 543-3738
Email: dfeifel@ucsd.edu
Biography
Dr. David Feifel earned a Bachelors of
Science, Master’s Degree and a Ph.D.(neurobiology) from the
University of Toronto, Canada, where he also earned a
Medical Degree. After completing an internship in Internal
Medicine at the Toronto General Hospital, Dr. Feifel
completed his residency training in Psychiatry at the
University of California, San Diego, where he served as
Chief Resident for the UCSD Outpatient Psychiatry Services
in 1994. In 1995 he joined the faculty of the Department of
Psychiatry in which he currently holds the rank of full
Professor. He is also a faculty member in the UCSD
Neurosciences Graduate Program. Dr. Feifel is the Director
of the Adult Psychiatric Services at UCSD Medical Center,
and the senior attending psychiatrist on the Neuropsychiatry
and Behavioral Medicine Inpatient Unit (NBMU). In addition
to being a Diplomate of the American Board of Psychiatry and
Neurology in General Psychiatry, he is also certified in the
subspecialties
Psychosomatic Medicine, and
Behavioral Neurology and Neuropsychiatry. He has
authored or co-authored numerous original scientific
research papers, abstracts and book chapters. Research Focus (See
Dr. Feifel Research)
Dr. Feifel engages in translational research
related to biological treatments for mental illness. He runs a
basic neuropsychopharmacology laboratory on the campus of the
UCSD Medical Center. His laboratory develops animal models to
explore the biological mechanisms underlying psychiatric
conditions such as psychosis and to assess the potential of
novel pharmacological treatments, particularly ones aimed at
neuropeptide targets. Dr. Feifel also heads a
clinical neuropharmacology research program at UCSD Medical
Center. Among other things, this program evaluates the safety
and efficacy of approved and investigational psychotropic
medications for a large variety of psychiatric indications and,
when possible, translates findings from his basic
neuropharmacology research program to clinical investigations.
Dr. has served as principal investigator in numerous clinical
studies evaluating treatments for conditions as diverse as
bipolar affective disorder, depression, schizophrenia, insomnia,
as well as childhood, adolescent, and adult attention deficit /
hyperactivity disorder (ADHD). His research has received funding
grants from the National Association for Research in
Schizophrenia and Depression (NARSAD), the Scottish Rite
Organization, the Stanley Medical Research Institute and the
National Institutes of Health.
Clinical Focus
Dr. Feifel’s clinical
focus is the diagnosis and treatment of psychiatric
disorders stressing a biological orientation. He is Director
of the
Adult Psychiatric Services at UCSD Medical Center, which
includes the Neuropsychiatry and Behavioral Medicine Unit (NBMU),
an 18-bed inpatient unit and the Consult / Liaison service.
The Psychiatry service at UCSD Medical Center, was ranked
among the nations best by US News and World Report in
2008. Dr. Feifel is founder and Director of the
UCSD Adult
ADHD Program. In addition to seeing patients, Dr. Feifel
lectures and/or supervises medical students, residents and
fellows in psychiatry and neurology at UCSD. He is a
national lecturer on topics in psychopharmacology. Among his
distinctions, Dr. Feifel is an Associate Member of the
American College of Neuropharmacology and a contributor to
the Expert Consensus Guidelines for Behavioral Emergencies. Selected Publications
-
Feifel D., Reza T.L., Wustrow D., and Davis D.M. Novel
Antipsychotic-Like Effects on Prepulse Inhibition of Startle
Produced by a Neurotensin Agonist. Journal of
Psychopharmacology Experimental Therapeutics 288:
710-713,1999
-
Feifel D. Rationale and Guidelines for the Treatment of Acute
Psychosis. Journal of Clinical Psychiatry, (Invited),
61 (Suppl 14):25-31,2000
-
Perry W., Minassian A., Feifel D. and Braff D.L. Sensorimotor gating
deficits in bipolar disorder patients with acute psychotic
mania. Biological Psychiatry 50:418-424,2001
-
Feifel, D,
Farber, RH, Clementz, BA, et al. (2004). Inhibitory deficits
in ocular motor behavior in adults with
attention-deficit/hyperactivity disorder. Biological
Psychiatry, 56(5), 333-9.
-
Feifel, D, Melendez, G, & Shilling, PD.
(2004). Reversal
of sensorimotor gating deficits in Brattleboro rats by acute
administration of clozapine and a neurotensin agonist, but
not haloperidol: a potential predictive model for novel
antipsychotic effects. Neuropsychopharmacology,
29(4), 731-8.
|